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Germ cells have a critical role in mediating the generation of genetic diversity and transmitting this information across gener-
ations. Furthermore, gametogenesis is unique as a developmental process in that it generates highly-specialized haploid
gametes from diploid precursor stem cells through meiosis. Despite the importance of this process, progress in elucidating the
molecular mechanisms underpinning mammalian germ cell development has been retarded by the lack of an efﬁcient and repro-
ducible system of in vitro culture for the expansion and trans-meiotic differentiation of germline cells. The dearth of such a culture
system has rendered the study of germ cell biology refractory to the application of new high-throughput technologies such as RNA
interference, leaving invivo gene-targeting approaches as the only option todetermine the function ofgenes believed to be involved
in gametogenesis. Recent reports detailing the derivation of gametes in vitro from stem cells may provide the ﬁrst steps in
developing new tools to solve this problem. This review considers the developments made in modelling germ cell development
using stem cells, and some of the challenges that need to be overcome to make this a useful tool for studying gametogenesis
and to realize any future clinical application.
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Introduction
The germ cells of sexually reproducing organisms have three crucial
functions, namely the preservation of genetic integrity, the generation
of genetic diversity and the transmission of this information to the next
generation through the production of haploid gametes from diploid
precursors. Perturbations at any stage of the gametogenic process
can result in subfertility, which within human populations is a major
public health issue affecting 0–15% of couples (De Kretser and
Baker, 1999). A better understanding of gametogenesis could aid
the development of new therapeutic approaches for subfertility and
provide targets for novel contraceptives. Despite these potential
beneﬁts, our understanding of the molecular mechanisms that regulate
the development of the mammalian germ lineage is poor when
compared with that of most somatic cells.
A major reason for this is the lack of a robust in vitro culture system
allowing the expansion of germline progenitor cells and their differen-
tiation into mature gametes. This has rendered the study of gameto-
genesis, and in particular the role of germ cell endogenous factors in
the regulation of this process, broadly resistant to recent technological
developments in high-throughout analysis of gene function, such as
the use of RNA interference to knockdown gene expression.
Previous efforts to establish in vitro models of germ cell develop-
ment have focused primarily on attempting to immortalize post-natal
spermatogenic cells. By introducing the SV40 large T antigen and a
temperature-sensitive mutant form of p53 into mouse testicular
germ cells, Hofmann et al. (1994) reported the establishment of an
immortalized germ cell line capable of undergoing meiosis in vitro
when grown at a permissive temperature. However, further character-
ization of this line failed to detect the presence of transcripts expressed
by post-meiotic cells, nor the presence of cells with a haploid DNA
content, leading to the conclusion that this cell line was incapable of
undergoing trans-meiotic differentiation in vitro (Wolkowicz et al.,
1996). Feng et al. (2002) used the TERT subunit of telomerase to
immortalize mouse spermatogonia capable of undergoing meiosis
and forming acrosome-like structures characteristic of haploid round
spermatids at high efﬁciency when treated with stem cell factor
(SCF, the ligand for the c-Kit receptor). Again this result has yet to
be replicated by other groups, and despite the potential utility of this
cell line to germ cell biologists, its use has not been widely reported.
Although methods to maintain and expand mouse spermatogonial
stem cells (SSCs) in culture have recently been developed, none
appear to support full trans-meiotic differentiation of these cells
in vitro (Kanatsu-Shinohara et al., 2003).
Indeed, the range of tools available to reproductive biologists to
determine the function of genes with a suspected role in mammalian
germ cell development is essentially limited to the study of
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NEW RESEARCH HORIZONhomologous genes in lower model organisms and the production of
transgenic mice with targeted disruptions of genes of interest
(Cooke and Saunders, 2002; Matzuk and Lamb, 2002; Lee et al.,
2007). While the success of this approach is undeniable, it is laborious,
time consuming and costly in comparison to in vitro cell-based assays
of gene function, compounded by the difﬁculty of maintaining mouse
lineswithreproductivedefectsthroughbreeding.Furthermore,targeted
gene disruptions in transgenic mice classically result in a complete
loss-of-function phenotype, and this may not accurately reﬂect some
instances of currently unexplained subfertility seen in human popu-
lations that may stem from more subtle hypomorphic alleles.
Alternative animal-based strategies to investigate germ cell devel-
opment have included the use of grafting gonadal fragments onto
immunocompromised mice (Paris and Schlatt, 2007), a technique
used elegantly by Naughton et al. (2006) to allow the study of the
effects of disrupting the glial cell line-derived neurotrophic factor
(GDNF) system on early spermatogenesis, overcoming the perinatal
mortality seen in GDNF-null mice. Isolation and genetic modiﬁcation
of SSCs, followed by transplantation back into a host testis to restore
spermatogenesis is another approach (Nagano et al., 2001, 2002;
Kanatsu-Shinohara et al., 2006), however, both of these techniques
require sufﬁcient time for grafts or transplants to become established.
The ability to generate ‘artiﬁcial’ (i.e. in vitro-generated) gametes
would also have potential therapeutic use where couples currently
require gamete donation through absence of their own (Nagy and
Chang, 2005). These include individuals suffering from a diverse
range of conditions including genetic causes both known (e.g. Y
chromosome deletions) and unknown, chromosomal abnormalities
(such as Turner’s and Klinefelter’s syndromes), and iatrogenically
following chemotherapy for cancer or inﬂammatory conditions.
Additionally, there is a need for oocytes for the reﬁnement of
somatic cell nuclear transfer for stem cell derivation, progress in
which is difﬁcult with the restricted numbers of oocytes available
through current donation programmes (Hall and Stojkovic, 2006).
What then are the alternative approaches available to study germ
cell development? Recent advances in the derivation of germ cells
from stem cells may hold some promise. The ﬁelds of research on
pluripotent stem cells (i.e. those capable of indeﬁnite self-renewal
and differentiating into all three germ layers in vitro or in vivo when
introduced into a blastocyst to form a chimera) and early germ cells
are historically deeply interlinked (Zwaka and Thomson, 2005).
Embryonal carcinoma cells (ECCs), the ﬁrst mammalian pluripotent
cells to be isolated and cultured, were derived from rare testicular
germ cell tumours known as teratocarcinomas (Solter, 2006). Work
establishing the optimal culture conditions for maintaining ECCs in
the undifferentiated state laid the foundations for the isolation and
propagation of embryonic stem cells (ESCs) from the pluripotent
inner cell mass of the mouse, and much later primate and human
blastocysts (Chambers and Smith, 2004; Solter, 2006).
Although themselves unipotent (capable only of giving rise to the
cell types of one lineage), germ cells share many transcriptional and
phenotypic similarities with ESCs (Zwaka and Thomson, 2005). Pri-
mordial germ cells (PGCs) are the last cells of the mammalian fetus
to retain expression of transcription factors Oct-3/4 (encoded by the
gene Pou5F1) and Nanog, involved in the maintenance of the undif-
ferentiated state (Pesce et al., 1998; Chambers et al., 2003; Chambers
et al., 2007), and they express similar cell surface markers to pluri-
potent stem cells such as alkaline phosphatase (Chiquoine, 1954).
The concept that a close relationship exists between germ cells and
stem cells is reinforced by the ﬁnding that under appropriate con-
ditions of in vitro culture, unipotent PGCs, and even post-natal and
adult spermatogonia, are capable of undergoing reprogramming into
a pluripotent state (Matsui et al., 1992; Resnick et al., 1992;
Kanatsu-Shinohara et al., 2004a; Guan et al., 2006).
This review focuses on recent developments in the in vitro model-
ling of germ cell development using stem cells with particular refer-
ence to the implications of these for the understanding of human
gametogenesis and defects therein. We address the major approaches
taken by stem cell biologists to study germ cell development, and
consider the challenges that need to be overcome to make these
technological developments useful research tools. Finally, we con-
sider how new work on the derivation of pluripotent stem cells from
terminally differentiated adult cells through the introduction of repro-
gramming factors has the potential to impact on the in vitro
modelling of germ cell development.
Germ cell development in rodents and humans
Producing accurate in vitro modelsof germ cell development is depen-
dent on understanding the normal process of establishing the germ
cell lineage in vivo. In lower organisms, such as Drosophila and
Caenorhabtidis elegans the germ cells are segregated from the soma
at the earliest stage of development through the asymmetric distri-
bution of proteins and mRNAs encoding factors required for germ
cell development (Lehmann and Ephrussi, 1994; Seydoux and
Schedl, 2001). In contrast, the formation of the ﬁrst germ cells in
mammals occurs comparatively late in development, through an
inductive process known as epigenesis (Saitou et al., 2002;
McLaren, 2003). This process has been most extensively studied in
the mouse, where PGCs arise in the proximal epiblast of the embryo
through the inductive action of extraembryonic ectoderm-derived
bone morphogenetic proteins (BMPs) (Lawson and Hage, 1994;
Lawson et al., 1999; Saitou et al., 2002). In mice, the earliest detect-
able precursors of the germ cell lineage are a group of six to eight cells
expressing the transcriptional repressor Blimp1 in the epiblast cell
layer adjacent to the extraembryonic ectoderm (McLaren and
Lawson, 2005; Ohinata et al., 2005). Although this small group of
Blimp1-positive cells is likely to constitute the ﬁrst lineage-restricted
germ cells in the embryo, surrounding cells may also be recruited to
form the population of 40 or so alkaline phosphatase-positive
‘founder’ PGCs detectable at the base of the allantois at e7.5
(McLaren and Lawson, 2005). Blimp1 appears to be essential for
the appropriate repression of the somatic Hox gene programme,
which would otherwise direct them into same fate as the cells that
surround them (Ohinata et al., 2005). Repression of the somatic
programme in PGC precursors occurs concomitantly with the
up-regulation of Stella (Dppa3), the earliest deﬁnitive germ cell
marker (Saitou et al., 2002).
From e8.5 in mice, the founder PGCs migrate through the embryo,
passing through the hindgut and the dorsal mesentery and arriving at
the genital ridges around e10.5, wherein they become known as gono-
cytes (McLaren, 2003). Germ cell proliferation occurs throughout the
migratory period, and continues for two to three days after colonizing
the gonads, forming a population of around 25 000 gonocytes at e13.5
when proliferation ceases (Tam and Snow, 1981). Subsequently, these
germ cells either cease mitosis and enter meiosis in the female, or pro-
gressively arrest in G0/G1 over several days in the male (Adams and
McLaren, 2002; McLaren, 2003; Western et al., 2008).
The precise events and timings surrounding the earliest events in the
establishment of the germ cell lineage in human embryos remain
unknown. Migratory human PGCs have been reported in the endo-
derm of the human embryo as early as the fourth week of develop-
ment, following a similar migratory path to that seen in mice
through the hindgut and dorsal mesentery arriving at the gonads
around the ﬁfth week of development (Witschi, 1948). Colonization
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later (Wartenburg, 1981).
The ﬁrst overt signs of sexual dimorphism between the male and
female gonads are detectable at around 6 weeks of development.
Sex determination and the onset of expression of the testis-
determining factor SRY in human fetal gonads occurs between
41 and 44 days post-ovulation in the gonads of male human fetuses,
and the subsequent organization of the somatic and germ cells of
the developing testis into the testicular cords is ﬁrst visible at 44
days post-ovulation (Wartenburg, 1981; Hanley et al., 2000).
Interestingly, at this stage of development the human fetal ovary is
reported to contain around 30 000 germ cells; ten times as many as are
present in the testis of a fetus of the same age (Bendsen et al., 2003,
2006). The gonocytes of both sexes continue to expand by mitosis
for a further 3 weeks, increasing 10-fold in number in both the testis
and the ovary (resulting in 30 000 and 250 000–300 000 germ cells
in the testis and ovary by 9 weeks post-fertilization, respectively)
(Bendsen et al., 2003, 2006). However, despite these radical differ-
ences in germ cell number, we have been unable to detect signiﬁcant
differences in the levels of expression of key germ cell-associated
genes such as deleted in azoospermia-like (DAZL) and the Dead-box
RNA helicase (VASA) between human fetal testis and ovaries,
although we do observe a signiﬁcant sexual dimorphism in the
expression of OCT-3/4 [A.J.C. and R.A.A. unpublished observations,
Anderson et al. (2007)]. Interestingly, no such sex-speciﬁc differences
in germ cell number have been reported in the mouse, in which both
male and female fetal gonads contain roughly equal numbers of
germ cells (Tam and Snow, 1981).
Key mouse/human differences in germ cell biology
Due to the regulatory, ethical and logistical difﬁculties in obtaining
sufﬁcient human fetal gonadal tissue for research, most studies into
mammalian germ cell development have focused on the mouse, in
the hope that these ﬁndings can be extrapolated to humans.
However, work from our laboratory and others has begun to demon-
strate that the differences between the two species in the sequence
of events surrounding germ cell development extend beyond merely
differences in timing.
Mouse PGCs express Oct-3/4 throughout their migratory period, and
in addition up-regulate expression of the cytoplasmic RNA-binding
proteins Dazl and Mvh (mouse vasa homologue, also known as
Ddx4) as they colonize the gonadal ridges and become gonocytes
(Fujiwara et al., 1994; Pesce et al., 1998; Seligman and Page, 1998;
Toyooka et al., 2000; Kehler et al., 2004). Expression of these
markers continues in male germ cells throughout the period of
mitotic arrest and beyond the resumption of spermatogenesis after
birth. Human gonocytes, in contrast, express only OCT-3/4 and
DAZL proteins. Consistent with previous reports studying older speci-
mens, DAZL protein localizes to the nuclei of gonocytes at this stage,
the functional signiﬁcance of which remains unknown (Rajpert-De
Meyts et al., 2004; Anderson et al., 2007). VASA protein is undetect-
able in proliferating human gonocytes, although they do produce
readily detectable amounts of VASA mRNA (Anderson et al., 2007),
indicating that the transcripts of this gene may be subjected to similar
translational regulation as occurs in the mouse (Reynolds et al., 2005).
In the human fetal ovary, the entry of gonocytes into meiosis is
coincident withthe loss of OCT-3/4 expression,the concomitant trans-
location of DAZL protein to the cytoplasm and the onset of detectable
VASA protein expression (Stoop et al., 2005; Anderson et al., 2007).
Whether these events are linked is unknown, but it is tempting to
speculate that the translocation of DAZL protein to the cytoplasm
might be necessary to allow the onset of translation of VASA
mRNA. In the testis, germ cells undergo a similar maturational
process, up-regulating DAZL and VASA, and down-regulating
OCT-3/4, although this appears not to be linked to meiotic entry
(Rajpert-De Meyts et al., 2004; Anderson et al., 2007).
Figure 1: Distinct subcellular localization of OCT-3/4, DAZL and VASA in
human fetal gonads.
In contrast to mouse gonocytes, which express Oct-3/4, Dazl and Mvh proteins,
ﬁrst trimester ovaries (a, 61 day), and testes (b, 64 day) express only OCT-3/4
(green) and DAZL (red) both of which co-localize to germ cell nuclei. In
ovaries from the second trimester (c, 14 week) DAZL protein is almost exclu-
sively cytoplasmic and largely localizes to OCT-3/4-negative groups of cells
(arrow); a few OCT-3/4-positive cells display low levels of DAZL expression
in their cytoplasm (arrowheads). In second trimester testes (d, 16 week; e,
19 week), DAZL is still expressed in the nuclei of some OCT-3/4-positive
germ cells but this pattern of expression is variable, with DAZL protein
present in the cytoplasm of OCT-3/4-positive and OCT-3/4-negative (arrow,
e) cells. (f) Mutually exclusive expression of OCT-3/4 and VASA in the
human fetal ovary; cells with intense immuno-positive staining for OCT-3/4
are found at the periphery of the organ (red nuclei), while cytoplasmic
VASA protein is most intense in cells located in nests (N) closer to the
centre of the ovary. An intermediate population of cells with low intensity
nuclear staining for OCT-3/4 and low intensity staining for VASA (arrow-
heads) was also present. (g) In second trimester human fetal testis, OCT-3/
4-positive and VASA-positive germ cells are found within the same seminifer-
ous cords; germ cells with intense nuclear OCT-3/4 expression (red nuclei) are
VASA-negative and those with intense cytoplasmic expression of VASA (e.g.
arrowed in inset g) were OCT-3/4-negative. Two other populations of male
germ cells can be identiﬁed; a population with low intensity expression of
both OCT-3/4 and VASA (arrowheads) and cells with nuclear VASA
expression (asterisks) which were typically found in pairs (adapted from
Anderson et al. (2007).
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markers between mouse and human during fetal germ cell develop-
ment. In the human fetal ovary, proliferating OCT-3/4-positive germ
cells are found at the periphery of the organ, with progressively
more mature meiotic germ cells found in a gradient towards the
centre (Fig. 1a–g) (Stoop et al., 2005; Anderson et al., 2007). This
is in contrast with the mouse ovary, in which germ cells enter
meiosis in a rostro-caudal wave along the long axis of the gonad
(Menke et al., 2003; Bullejos and Koopman, 2004). In mice, the
switch from mitotic proliferation to meiotic differentiation has been
reported to be initiated by the diffusion of retinoic acid (RA) from
the mesonephric duct into the most rostral part of the ovary, and its
subsequent diffusion along the gonad (Bowles et al., 2006; Koubova
et al., 2006), although this claim remains controversial and other
mechanisms for regulating meiotic entry may exist (Best et al.,
2008). Given the arrangement of germ cells in the human fetal
ovary, it is difﬁcult to envisage how such an analogous system
could work, and the mechanisms regulating meiotic entry in human
germ cells remain to be determined.
Another recently identiﬁed species-speciﬁc difference relates to the
expression of the transcription factor SOX2, which is expressed in
mouse, but not human germ cells (Perrett et al., 2008). SOX2 is a com-
ponent of the core transcriptional machinery involved in the mainten-
ance of pluripotency in stem cells, and works through binding the
promoters of many pluripotency-associtated genes in concert with
OCT-3/4 (Niwa, 2007). The functional signiﬁcance of the lack of
SOX2 expression in human germ cells is presently unclear, as they
continue to express many of the genes considered dual OCT-3/4–
SOX2 targets (Perrett et al., 2008). A screen to identify other germ
cell-expressed SoxB-class transcription factors (the subfamily to
which SOX2 belongs) that might substitute for SOX2 found none,
suggesting that no functional redundancy exists within the SoxB sub-
family in germ cells (Perrett et al., 2008). Looijenga and colleagues
have suggested that SOX17 may fulﬁl this role instead (de Jong
et al., 2008). These data are interesting given the suggestion that
OCT-3/4 may fulﬁl different functions in germ cells and stem cells
through modulating different sets of target genes (Hubbard and
Pera, 2003; Kehler et al., 2004).
The differences in localization and onset of expression of these
marker genes relative to the stage of germ cell maturation suggest sig-
niﬁcant differences may exist in the control of germ cell development
between mouse and human. Differences between the two species are
not limited to spatiotemporal variations in marker gene expression
however. Rodents also lack some of the candidate fertility factors
known to be clinically relevant in humans. For example, the human
Y-linked DAZ genes, which are candidate azoospermia factors in
humans, have only autosomal homologues in mice (Reijo et al.,
1995; Ruggiu et al., 1997). Therefore, while the study of such homol-
ogues can provide critical insight into the biology of the DAZ family
proteins (Ruggiu et al., 1997), the clinically relevant condition of Y
chromosome microdeletions encompassing the DAZ gene cluster
cannot be replicated directly in rodents. There are, therefore, substan-
tial limitations in using rodent models to understand human fertility
and the aetiology of human infertility.
Strategies for in vitro culture of PGCs
A signiﬁcant research effort by numerous labs worldwide has estab-
lished roles for kit ligand/SCF, leukaemia inhibitory factor (LIF),
basic ﬁbroblast growth factor (bFGF), BMPs, forskolin and RA in the
maintenance or expansion of isolated mouse PGCs and proliferating
gonocytes in vitro (reviewed in De Felici and Pesce, 1994; Donovan,
1994; De Felici et al., 2004). While the study of the effects of some
of these factors (especially SCF and RA) on germ cell development
in vitro has provided signiﬁcant insight into their role in vivo, the rel-
evance of data acquired in vitro on others is unclear. For example,
mice carrying a germ cell-speciﬁc deletion of gp130, the common
receptor for interleukin-6 family ligands (which includes LIF),
develop a normal complement of PGCs (Molyneaux et al., 2003),
whereas blocking the gp130 receptor with an antibody results in the
death of isolated PGCs cultured in vitro (Koshimizu et al., 1996), or
suppression of meiotic entry (Chuma and Nakatsuji, 2001).
Despite the inclusion of these factors in culture media, PGCs or
gonocytes have a limited proliferative lifespan in vitro, before under-
going either death or differentiation (Donovan, 1994). Furthermore, in
the absence of appropriate programming from the somatic cells of the
gonad, isolated male PGCs will enter meiosis in vitro at the same time
as those isolated from female gonads, thus making the investigation of
sex-speciﬁc differences in germ cell biology difﬁcult to study ex vivo
(Nakatsuji and Chuma, 2001).
Little is known about the behaviour of isolated human PGCs and
gonocytes in culture. Shamblott et al. (1998) reported two populations
of human gonocytes in culture, namely ‘stationary’ (round, non-
migratory) and ‘migratory’ (motile cells with long processes) germ
cells. Turnpenny et al. (2003) described populations of poorly-
proliferating and vigorously-proliferating human germ cells, though
whether these populations are linked to the populations reported by
Shamblott et al. is unclear. More recently, Tu et al. (2007) have
also identiﬁed that human gonocytes divide into two distinct morpho-
logical populations (‘round’ and ‘spindly’), and that treatment with
SCF increased the numbers of ‘round’ germ cells in culture compared
with those with the ‘spindly’ morphology’. We have identiﬁed similar
phenomena while trying to culture human gonocytes isolated from
fetuses of 60 days gestational age on feeder layers of mitotically
inactivated STO cells (Fig. 2a–d). How these populations relate to
differences in the germ cells in vivo is unknown, but warrants
further investigation.
EGCs: stem cells from PGCs
Matsui et al. (1992) and Resnick et al. (1992) reported the establish-
ment of long term exponentially expanding cultures of mouse PGCs.
Figure 2: Morphology of human fetal gonocytes in vitro.
When cultured in vitro on feeder layers of mitotically inactivated STO cells,
gonocytes isolated from ﬁrst trimester testes or ovaries (60–65 days gesta-
tional age) adopt one of two morphologies, namely round (a, b and d)o r
migratory (c and d). Both populations can be found in close proximity (d).
Germ cells, but not feeders, display strong alkaline phosphatase activity (red).
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layer in the presence of LIF, SCF and bFGF, small numbers of
PGCs escaped the in vitro block on proliferation and acquired the
ability to divide indeﬁnitely (Matsui et al., 1992; Resnick et al.,
1992). These proliferating germ cells could also contribute to a
chimera when introduced to a blastocyst (Labosky et al., 1994).
Germ cells that have undergone this ‘reprogramming’ event in
culture cells are known as embryonic germ cells (EGCs).
Derivation of EGCs from human PGCs/gonocytes was ﬁrst reported
shortly after the derivation of human ESCs (hESCs), using culture
conditions similar to those used to derive mouse EG cells (Shamblott
et al., 1998; Turnpenny et al., 2003; Liu et al., 2004). Unlike hESCs
however, hEGCs do not appear to be fully pluripotent (Aﬂatoonian
and Moore, 2005; Turnpenny et al., 2006). Although capable of
giving rise to representative tissues of all three germ layers in vitro,
it has not yet been demonstrated that hEGCs are capable of forming
teratomas when introduced into immunocompromised mice (the stan-
dard test of pluripotency for hESCs in the absence of a chimera-
forming assay) (Shamblott et al., 1998; Turnpenny et al., 2003;
Turnpenny et al., 2005).
The exact status of hEGCs remains unclear as the repertoire of cell
surface antigens they express differs from that expressed by hESCs.
Undifferentiated hESCs express the stage-speciﬁc embryonic antigens
SSEA3 and SSEA4, and up-regulate the SSEA1 antigen on differen-
tiation (Thomson and Odorico, 2000). hEGCs appear to express all
three simultaneously, although this too differs from the in vivo situ-
ation where human gonocytes express SSEA1, and the expression of
SSEA4 is not restricted to the germ cells in the gonad (Shamblott
et al., 1998; Kerr et al., 2008). The recent ﬁnding that both human
gonocytes and hEGCs do not express SOX2 indicates that the latter
are at least in part representative in vitro derivatives of the former,
and the lack of SOX2 expression in hEGCs may in part explain
their lack of total pluripotency (Perrett et al., 2008).
Surprisingly, given their germ cell origin, the possibility of using
EGCs as an in vitro model for studying germ cell behaviour has not
been extensively explored. Toyooka et al. (2000) reported that cultur-
ing mEGCs in aggregates with somatic gonadal cells resulted in the
up-regulation of Mvh expression (and by extension germ cell for-
mation in vitro), a response not seen when mESCs were used in
similar aggregate cultures. Although this overlooked result perhaps
represents the ﬁrst demonstration of germ cell derivation from a plur-
ipotent stem cell, it more importantly indicates that unlike mESCs,
mEGCs may inherit the ability to respond to signals from the
gonadal microenvironment from the germ cells from which they
were derived (Toyooka et al., 2000). EGCs may therefore represent
a potential source of reproducible in vitro-derived germ cells for the
study of germ-soma gonadal interactions.
There are difﬁculties however in the use of hEGCs. They are difﬁ-
cult to maintain in culture compared with hESCs (Aﬂatoonian and
Moore, 2005; Turnpenny et al., 2005), they appear not to retain
their pluripotency for longer than 15–20 passages and cyropreserva-
tion has proved difﬁcult (Shamblott et al., 1998; Turnpenny et al.,
2005). Despite this, EGCs may still provide a valuable model for
some studies of germ cell development.
Within our own laboratory we have recently investigated the poten-
tial for hEGCs to act as a useful model system for investigating early
human germ cell development. As with previous reports, we have
found these cells difﬁcult to identify in culture by light microscopy
without ﬁxing and staining for alkaline phosphatase activity, and the
efﬁciency of derivation in our hands is signiﬁcantly lower than that
previously reported (Shamblott et al., 1998). We have however, suc-
ceeded in establishing proliferative cultures of putative hEGCs from
fetal gonads lasting several weeks (Fig. 3a–d) and efforts to determine
which, if any, characteristics of PGCs are retained following their
conversion to EGCs are underway.
Pluripotent stem cell-derived gametes: making
germ cells from stem cells
Although pluripotent ESCs are capable of contributing to the germline
of chimaeric embryos and forming fully functional gametes in vivo
(Bradley et al., 1984), Toyooka et al. (2000) were unable to detect
the induction of Mvh expression in co-cultures of mESCs and
gonadal somatic cells, suggesting that mESCs were either unrespon-
sive to the gonadal signals inducing germ cell development, or that
the signals produced by somatic cells at this stage were insufﬁcient
to induce germ cell development. Subsequent successful derivation
of germ cells from ESCs in vitro in 2003 was a signiﬁcant break-
through, and one likely to have signiﬁcant impact on the study of
germ cell development (Hubner et al., 2003). Table I gives the
major ﬁndings of the publications in this ﬁeld to date.
Hubner et al. (2003) ﬁrst reported the derivation of germ cells from
mESCs. They harnessed a green ﬂuorescent protein (GFP) reporter
construct fused to part of the mouse Oct-3/4 promoter gene that
restricted expression of the reporter gene to early germ cells and
were thus able to detect increasing numbers of GFP-positive cells
when mESCs were bulk differentiated in a monolayer. Analysis of
the GFP-positive cells after sorting revealed that they had differen-
tiated into early germ cells on the basis of the expression of germ
cell markers c-Kit and Mvh. Extended culture of these cells resulted
in the formation of aggregates that detached from the culture
surface and expanded in suspension, forming structures resembling
ovarian follicles, comprising an oocyte with associated somatic cells.
Consistent with these structures being follicle-like, they were found
to release estradiol into the culture medium. Eventually, the follicle-
like structures extruded the putative oocytes, and in some instances
the formation of blastocyst-like structures was detected, apparently
through a parthenogenetic mechanism (Hubner et al., 2003).
Shortly after the report of mESC-derived ‘oocytes’, two other
groups reported the derivation of male germ cells from mESCs.
Geijsen et al. (2004) differentiated mESCs into three-dimensional
cellular aggregates known as embryoid bodies (EBs), a system that
Figure 3: Colonies of putative human EGCs derived from cultured human
gonocytes.
Proliferative cultures of putative human EGCs at late passage 2 (3 weeks in
culture), stained for alkaline phosphatase activity (red). Note the variable stain-
ing intensity within colonies from regions of strong (arrows, a, c and d) to weak
(arrowheads, a, c and d) staining. Cultures were often found in association with
aggregations of feeders carried over during subculture (asterixes).
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surface markers that can be used to sort PGCs from ESCs, Geijsen
et al. sorted rare SSEA1-positive cells from EBs that may represent
early germ cells or remaining undifferentiated mESCs, and cultured
them in the presence of RA, which promotes PGC proliferation but
mESC differentiation. Under these conditions, colonies of alkaline
phosphatase-positive cells formed that could be cultured indeﬁnitely
under mESC culture conditions. These cells progressively underwent
imprint erasure, a hallmark of germ cell development in vivo. This,
coupled with the unlimited proliferative potential of these cells led
the authors to suggest that these cells were probably equivalent to
mEGCs—pluripotent derivatives of the EB-derived PGCs (Geijsen
et al., 2004). Extending the culture period of the EBs for a further
3–4 weeks, followed by sorting of cells based on the expression of
a marker of the acrosome, a structure found only in post-meiotic
spermatids—revealed the existence of a haploid cell population.
Importantly, isolation of these haploid sperm-like cells and their use
in intracytoplasmic sperm injection (ICSI) resulted in oocyte fertiliza-
tion and embryonic progression to a morula-like stage but no further,
probably due to imprinting defects in the mESC-derived sperm-like
cells (Geijsen et al., 2004). Transcripts for anti-Mu ¨llerian hormone
(Amh) and the luteinizing hormone receptor (Lhr) were found in
EBs, suggesting that gonadal somatic-like cells were arising in
tandem with germ cells (Geijsen et al., 2004). If indeed germ cells
and their supporting gonadal somatic cells are closely associated
within EBs, this may lead to new insights into the molecular architec-
ture of the germ cell niche.
Toyooka et al. (2003) found that when co-cultured with somatic
cells expressing Bmp4, small numbers of mESCs up-regulated
GFP-o rLacZ-reporter genes under the control of the Mvh promoter,
reﬂecting commitment to the germ cell lineage. Mixing the GFP- or
LacZ-positive cells with fetal gonadal somatic cells and implantation
of the aggregates beneath the testis capsule resulted in the formation of
seminiferous tubule-like structures distinct from those of the host
testis. These tubules appeared to contain normal spermatogenesis,
and morphologically normal spermatozoa with condensed nuclei and
tails. Sperm isolated from the transplant-derived tubules were found
to contain the LacZ transgene, demonstrating that they were indeed
derived from mESCs, although the fertilizing ability of the sperm
was not reported (Toyooka et al., 2003).
Subsequently, Lacham-Kaplan et al. (2006) reported that EBs
cultured in media conditioned by cultures of neonatal testicular cells
gave rise to ovary-like structures containing cells expressing oocyte-
speciﬁc markers with remarkably high frequency (83%), although
replication of this result has yet to be reported. Novak et al. (2006)
derived follicle-like structures similar to those seen by Hubner et al.
(2003) but found that they were unable to correctly progress through
meiosis, indicating that although in vitro haploid germ cell formation
has been reported, synapsis, recombination and appropriate segre-
gation of chromosomes may not occur.
Building on earlier work in teratocarcinoma and bone-marrow-
derived stem cells, Nayernia et al. (2006b) reported the production
of live offspring from sperm produced in vitro. Using two ﬂuorescent
reporter genes (GFP and DsRed) under the control of spermatogonia-
Table I. Major developments in pluripotent stem cell-derived gametes.
Source material Method Endpoint Reference
Mouse ES cells Monolayer differentiation, followed by sorting on cell
surface markers
Formation of follicle-like structures, progressing to
blastocyst-like structures by possible
parthenogenesis
Hubner et al.
(2003)
Mouse ES cells Formation of EBs, isolation of SSEA1-positive cells EG-like cells isolated when rare residual
SSEA1-positive cells isolated from EBs and
cultured in presence of RA
Geijsen et al.
(2004)
Isolation of cells with haploid DNA content
expressing post-meiotic male germ cell markers
after extended EB differentiation
Fertilization of oocytes with sperm-like cells,
progression to morula stage embryo
Mouse ES cells Mvh-LacZ ES cells cultured in aggregates with
BMP4-expressing somatic cells
Aggregates formed new tubule structures de novo
under testis capsule. All stages of spermatogenic
cells detectable
Toyooka et al.
(2003)
LacZ-positive ES cells isolated and aggregated with fetal
gonadal somatic cells, transplanted into testis capsule
Functionality of sperm not tested
Human ES cells ES cells differentiated into EBs Transcripts for PGC, pre-meiotic and post-meiotic
germ cells expressed in time-dependent fashion
during course of differentiation. Detection of
VASA protein in cells at periphery of EBs
Clark et al. (2004)
Failure of meiosis, simultaneous detection of male
and female germ cell transcriptional programme
irrespective of ES cell karyotype
Porcine skin-derived
stem cells
Differentiation into sphere-like structures, oocyte-like cells
cultured in presence of porcine follicular ﬂuid
Follicle-like structures containing oocytes with
zona pellucida-like casings
Dyce et al. (2005)
Progression to blastocyst stage when fertilized
Mouse ES cells Differentiation into EBs in the presence of testicular
cell-conditioned medium
Ovary-like structures containing oocyte-like cells
produced at high efﬁciency
Lacham-Kaplan
et al. (2006)
Mouse ES cells Stimulation with RA, isolation and culture of
Stra8-GFP-positive cells, subsequent differentiation into
‘haploid’ cells expressing post-meiotic Prm1-DsRed reporter
Haploid sperm like-cells isolated, used in ICSI
producing live mice, although these died shortly
after birth due to suspected imprinting defects
Nayernia et al.
(2006b)
EB, embryoid bodies; EG, embryonic germ; BMP, bone morphogenic protein; ES, embryonic stem; RA, retinoic acid, PGC, primordial germ cell;
SSEA, stage-speciﬁc embryonic antigen.
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506(Stra8) and post-meiotic spermatid-speciﬁc (Prm1) promoters respect-
ively, they were able to track the progression of mESC-derived germ
cells through the spermatogenic process and isolate cells with a sperm-
like morphology. Use of these cells for ISCI resulted in a number of
pregnancies, although the majority died in utero and the remainer
died within a few months of being born, probably as a result of
imprinting defects (Nayernia et al., 2006b). This development, if
able to be replicated, would represent a signiﬁcant step forward, and
suggest that differentiation of mESCs into germ cells has the potential
to produce fully functional gametes.
Progress in producing germ cells from human ESCs has been less
successful. To date, Clark et al. (2004) are the only group to have
reported the successful formation of germ cells from hESCs differen-
tiated into EBs. Differentiation of hESCs over a period of 2 weeks
resulted in a steady decline in the levels of pluripotency markers
NANOG and OCT-3/4, and an up-regulation of germ cell-speciﬁc tran-
scripts including VASA, SYCP1 and PUMILIO-2. Of particular interest
is the ﬁnding that differentiating hESCs expressed both the oocyte-
speciﬁc gene GDF9 and the spermatid-speciﬁc gene TEKT1 irrespec-
tive of whether the cells were karyotypically female (XX) or male
(XY) (Clark et al., 2004). Consistent with the report that mESC-
derived oocytes were unable to correctly undergo meiosis (Novak
et al., 2006), Clark et al. (2004) were unable to detect hESC-derived
germ cells undergoing normal meiosis as judged by the formation
of synaptonemal complexes. The simultaneous activation of both
the male and female germ cell transcriptional programmes in hESC-
derived germ cells may explain the meiotic failure seen in hESC-
derived germ cells.
Uses and limitations of stem cell-derived gametes
Despite initial promise there has been little progress using this system
as a model for gametogenesis. Germ cell derivation remains very
inefﬁcient with less than one of one million starting cells becoming
a germ cell (Geijsen et al., 2004). Why the efﬁciency of this process
is so low is unclear, though it may be related to the failure of
meiosis seen by Novak et al. and/or the simultaneous activation of
both male and female germ cell programmes in ESC-derived
gametes resulting in meiotic catastrophe (Clark et al., 2004; Novak
et al., 2006). Methodologically, culturing cells in high glucose
media appears to be beneﬁcial for deriving germ cells from mESCs
(Mizuno et al., 2006), and supplementing culture media with a cock-
tail of recombinant BMP4, 7 and 8b has been reported to enhance the
efﬁciency of germ cell derivation from hESCs (Kee et al., 2006).
The recent ﬁnding that some hESC lines display greater propensities
to differentiate along certain lineages than others is of particular interest
(Osafune et al., 2008) and suggests that some ESC lines could produce
gametes more efﬁciently that others. Although Clark et al. (2004) were
unable toﬁnd signiﬁcantdifferences inthe expression levels ofmultiple
germ cell-associated genes in three independent undifferentiated hESC
lines, the quantitative RT–PCR method used in their experiment could
only provide a global overview of the transcriptional landscape of the
entire hESC population analysed. It is likely that stochastic differences
in gene expression between individual ESCs within a differentiating
population will have some inﬂuence on cell fate decisions. Indeed,
immunostaining of undifferentiated mESCs and hESCs reveals a non-
uniform pattern of markers including Nanog, Stella, and Dazl within
individual colonies (Clark et al., 2004; Payer et al., 2006; Chambers
et al., 2007).
A major potential beneﬁt of using stem cells to model germ cell
development is the ability to carry out genetic modiﬁcations in the
starting cell population. Although the genetic modiﬁcation of PGCs
has been demonstrated using retroviruses (De Miguel et al., 2002),
low survival rates and poor differentiation of isolated PGCs in vitro
makes this a laborious system. Transgenes on the other hand can be
readily introduced to ESCs, and clonal lines in which the construct
has integrated can be isolated using drug selection. Furthermore,
rather than having to use homologous recombination to target a
gene for disruption, it should be possible to introduce siRNA con-
structs that target-speciﬁc genes of interest into the undifferentiated
ESC population prior to differentiating them into germ cells. Knock-
ing down speciﬁc genes in ESCs then assaying their ability to form
germ cells when differentiated in vitro could provide a more rapid
and efﬁcient method for identifying new candidate fertility genes.
The apparent failure of stem cell-derived gametes to undergo
meiosis efﬁciently could also provide opportunities to study the mol-
ecular mechanisms regulating meiotic progression and provide insight
into the causes of meiotic failure.
Stage-speciﬁc approaches to modelling
germ cell development
Rather than attempting to recapitulate the entire germ cell differen-
tiation pathway from ESCs in vitro, which appears to happen only
with very low efﬁciency, recent developments in stem cell research
may offer the opportunity to study speciﬁc stages of the process
in vitro using cell lines derived from different stages.
In vivo the germ cell population arises from the proximal epiblast of
the post-implantation embryo (McLaren, 2003). Whether the cells
within an EB that give rise to germ cells in vitro go through a
similar epiblast-like stage early in their differentiation is yet to be
established, although the ﬁnding that treatment with BMPs increases
the efﬁciency of ESC-derived germ cell formation might suggest
that this is the case (Kee et al., 2006). Two groups have recently
reported the isolation and culture of pluripotent stem cells from the
mouse epiblast (Brons et al., 2007; Tesar et al., 2007). These cells
can be expanded and maintained in the undifferentiated state under
the same culture conditions as hESCs (in the presence of activin/
nodal and FGF, rather than LIF) and display a morphology and
transcriptome more akin to that of hESCs than mESCs. Treatment
of epiblast stem cells with BMP4 resulted in the up-regulation of
Blimp1 within 24 h, followed by later Stella, thus recapitulating the
sequence of changes in gene expression seen during the earliest stages
of germ cell formation (Tesar et al., 2007). The efﬁciency of germ
cell induction from epiblast stem cells has not yet been reported, but
as undifferentiated epiblast stem cells do not express germ cell
markers such as Dazl and Stella (Tesar et al., 2007), they may provide
a cleaner model for the study of early germ cell development than
ESCs, which express many supposedly ‘germ cell-speciﬁc’ transcripts.
New developments in the study of germline stem cells may also
present opportunities to study the later stages of gametogenesis in
vitro. Several groups have reported the isolation of SSCs and their
expansion in culture (Kanatsu-Shinohara et al., 2003; Kubota et al.,
2004). Although no reports of in vitro differentiation of SSCs to
haploid sperm have been forthcoming, these cells can be transplanted
back into recipient testes and re-establish spermatogenesis
(Kanatsu-Shinohara et al., 2003). The genetic modiﬁcation of SSCs
in vitro has been demonstrated (Nagano et al., 2001, 2002;
Kanatsu-Shinohara et al., 2004b, 2006). Combining the introduction
of overexpression or knockdown constructs into SSCs with their sub-
sequent transplantation back into recipient testes may offer a viable
alternative approach for investigating the effect of disrupting candi-
date fertility genes on spermatogenesis.
Comparable developments may not be possible in the female as
there is believed to be no analogous germ stem cell in the ovary.
Work by Johnson et al. (2004, 2005) has challenged this with a
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natal mouse ovary, possibly deriving from bone marrow, which can
replenish the primordial follicle pool. Although this work remains
highly controversial (Telfer et al., 2005), it does reopen the prospect
that a rare germline stem cell population exits within the post-natal
ovary. The ﬁnding that bone marrow-derived stem cells from both
mouse and human can form cells with spermatogenic characteristics
may support this (Nayernia et al., 2006a).
Other strategies for manipulating cell differentiation
A major breakthrough likely to impact on the ﬁeld of germ cell
research is the recent discovery that differentiated adult cells can be
reprogrammed into pluripotent stem cells. By introducing a cocktail
of transgenes (Oct-3/4, Sox2, Klf4 and c-Myc), mouse ﬁbroblasts
could be reprogrammed to ESC-like ‘induced pluripotent cells’ (iPS
cells) capable of differentiating into all three germ layers in vitro
and in vivo (Takahashi and Yamanaka, 2006). The same group and
others have since demonstrated that the same effect is achievable in
terminally differentiated human dermal ﬁbroblasts (Takahashi et al.,
2007). It has since been reported that the use of c-Myc, the inclusion
of which resulted in tumours in chimaeras mice produced using iPS
cells, is dispensable for the derivation of both human and mouse iPS
cells, although the use of viral vectors to introduce transgenes still
poses a risk of insertional mutagenesis (Yu et al., 2007; Nakagawa
et al., 2008). Whether human iPS cells are capable of generating
germ cells in vitro has yet to be demonstrated but this approach has
the potential to greatly increase access to pluripotent stem cells,
especially for researchers in countries where hESC derivation or
research is limited or banned by law.
Therapeutic potential
The use of ESC-derived gametes in assisted reproduction treatments
remains a distant prospect. At present it would require the cloning
of an individual, derivation of stem cells from the resultant blastocyst
and the subsequent derivation of gametes from them. The recent dis-
covery of iPS technology may offer a shortcut by allowing the creation
of pluripotent stem cells directly from a patient’s tissues that could
then be used as a source of cells from which gametes could be
derived in vitro. Even if these challenges could be overcome, major
obstacles to the use of in vitro-derived gametes will still exist. The
greatest of these is safety. Although cells with a haploid DNA
content have been created in vitro whether they consistently form
with the correct chromosome complement has yet to be demonstrated.
hESCs have been shown to show chromosome gain during extended
periods of culture (Draper et al., 2004), so any future use in therapy
would require tight quality control procedures and frequent assaying
for chromosomal aberrations.
Perhaps most importantly however, the appropriate erasure and
re-establishment of sex-speciﬁc patterns of genomic imprints will
need to be demonstrated. The mEGC-like cells generated by culturing
mESC-derived PGCs were found to erase imprints, but no data were
presented as to whether the correct androgenetic imprinting pattern
was installed when EBs were allowed to differentiate for longer and
produce haploid sperm-like cells (Geijsen et al., 2004). The inability
of mESC-derived sperm to support development beyond the morula
stage would suggest that, at least in part, it was not (Geijsen et al.,
2004). Inconsistent erasure and re-establishment of imprints in
mESC-derived sperm has been reported and is likely to underpin the
premature death and phenotypic abnormalities seen in the offspring
produced using in vitro-produced sperm (Nayernia et al., 2006b).
However, quite what level of proof would be required before in
vitro-derived gametes could be used therapeutically remains unclear.
Indeed, it could be argued that existing reproductive technologies
(most notably ICSI) have been adopted without extensive safety
analysis, and there remains a concern that assisted reproductive
technologies may result in a higher frequency of imprinting
defect-associated conditions such as Beckwith–Wiedeman syndrome
(Cox et al., 2002; Maher et al., 2003; Allen and Reardon, 2005).
Certainly, robust molecular and biochemical documentation of the
appropriate resetting of imprints in hESC-derived gametes would be
a prerequisite, as too would large-scale karyotyping analyses demon-
strating that in vitro-derived gametes were repeatedly produced with
the appropriate chromosome number. Determining whether meiosis
and recombination occur appropriately during the process of deriving
germ cells from pluripotent stem cells is also of some importance,
given the suggestion that ESC-derived gametes are unable to complete
meiosis (Clark et al., 2004; Novak et al., 2006). Should the meiotic
process proceed in vitro without recombination, it would produce
gametes genetically identical to the donor cells from which they
were derived, albeit with half the number of chromosomes, which
arguably has ethical implications for the identity of the offspring.
In the shorter term, ESC-derived artiﬁcial gametes have the poten-
tial to make a signiﬁcant clinical impact in two ways. First, a major
practical application for all stem cell-derived tissues is in toxicity
screening for drugs in development (Rubin, 2008). The effects of can-
didate drugs on stem cell-derived gametes could provide useful pre-
clinical insight into the potential effects of any drug on reproductive
function both in screening for toxicity and for application in contra-
ception, and could be extended to investigate the impact of environ-
mental chemicals on germ cell development. Secondly, the short
supply of good-quality human oocytes for use in somatic cell
nuclear transfer experiments is a major factor limiting research into
the generation of so-called ‘patient-speciﬁc’ hESC lines with great
potential therapeutic beneﬁt (Hall and Stojkovic, 2006). Should the
derivation of oocytes from mESCs be repeated using hESCs, it may
be that this route could provide a potentially limitless source of
in vitro-derived oocytes that can be used as recipients for somatic
cell nuclear transfer (Hubner et al., 2003; Nagy and Chang, 2007).
Conclusions
The use of stem cells to model germ cell development in vitro remains
an avenue of research which is still very much in its infancy. Conﬁr-
mation of the reports of Hubner et al. (2003), Toyooka et al.( 2 0 0 3 )
and Geijsen et al. (2004) at least in part by other groups (Novak
et al., 2006; Kerkis et al., 2007), demonstrates that this approach will
be of scientiﬁc use, and it is likely that issues of efﬁciency and robust-
ness will be resolved. Information obtained from in vitro germ cell
models will reciprocally inform the study of human germ cell develop-
ment, complimenting data derived from fetal material. As the pro-
gression of in vitro-produced human germ cells has yet to pass the
premeiotic stage (Clark et al., 2004), the prospect of this technology
being used for therapeutic beneﬁt remains a distant but exciting possi-
bility. The rapid advancement of stem cell research, particularly with
respect to iPS technology, suggests that useful in vitro approaches to
modelling germ cell development are unlikely to be a long way off.
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